Patents by Inventor Randen L Patterson

Randen L Patterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8080367
    Abstract: Anti-cancer drugs are identified by screening for agents and compounds which inhibit the binding of HSP90 and IP6K2. In vitro and in vivo assays can be used. Any phenomenon associated with the binding or inhibition can be monitored, including cell death, subcellular localization, catalytic activity of IP6K2, and IP7 formation.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: December 20, 2011
    Assignee: The Johns Hopkins University
    Inventors: Solomon H. Snyder, Anutosh Chakraborty, Michael Koldobskiy, Katherine Sixt, Krishna Juluri, Asif K Mustafa, Damian B Van Rossum, Randen L Patterson
  • Publication number: 20100129806
    Abstract: Anti-cancer drugs are identified by screening for agents and compounds which inhibit the binding of HSP90 and IP6K2. In vitro and in vivo assays can be used. Any phenomenon associated with the binding or inhibition can be monitored, including cell death, subcellular localization, catalytic activity of IP6K2, and IP7 formation.
    Type: Application
    Filed: December 11, 2007
    Publication date: May 27, 2010
    Applicant: The Johns Hopkins University
    Inventors: Solomon H. Snyder, Anutosh Chakraborty, Michael Koldobskiy, Katherine Sixt, Krishna Juluri, Asif K. Mustafa, Damian B. Van Rossum, Randen L. Patterson